Design Therapeutics Inc (DSGN) Unusual Options Activity Today

Checking DSGN unusual options activity helps you spot when traders are making outsized bets on Design Therapeutics Inc before the broader market catches on. Design Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor DSGN unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching DSGN unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking DSGN unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and DSGN unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs.

It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Catalysts rarely arrive without a footprint, and DSGN unusual options activity is often where that footprint shows up first. Our scanner tracks Design Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at DSGN unusual options volume on the call side or chasing put sweeps, Design Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.